Sari Fishman
Corporate Officer/Principal en CAN-FITE BIOPHARMA LTD. .
Fortuna: - $ al 31/03/2024
Perfil
Sari Fishman is a professional with a background in business development and clinical affairs.
She is currently working as the Vice President of Business Development at Can-Fite BioPharma Ltd.
She started this position in 2017.
Previously, she worked as the Director of Clinical Affairs at OphthaliX, Inc. Dr. Fishman holds a doctorate degree from Bar-Ilan University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CAN-FITE BIOPHARMA LTD.
-.--% | 28/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Cargos activos de Sari Fishman
| Empresas | Cargo | Inicio |
|---|---|---|
| CAN-FITE BIOPHARMA LTD. | Corporate Officer/Principal | 01/01/2014 |
Antiguos cargos conocidos de Sari Fishman.
| Empresas | Cargo | Fin |
|---|---|---|
OphthaliX, Inc.
 OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Chief Tech/Sci/R&D Officer | - |
Formación de Sari Fishman.
| Bar-Ilan University | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| CAN-FITE BIOPHARMA LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
OphthaliX, Inc.
OphthaliX, Inc. Pharmaceuticals: MajorHealth Technology OphthaliX, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of therapeutic products for ophthalmic disorders. Its portfolio includes CF101 oral drug that intends to treat glaucoma and uveitis. The company was founded by Ilan Cohn on December 10, 1999 and is headquartered in Petach Tikva, Israel. | Health Technology |
- Bolsa de valores
- Insiders
- Sari Fishman
